02.12.2010 • NewsAshlandSüd-ChemieASK Chemicals

EU Clears Ashland, Sud-Chemie Joint Venture

U.S. chemicals company Ashland and Sud-Chemie secured European Union regulatory approval on Tuesday to set up a joint venture in the foundry chemical sector.

The companies said in July they would merge their worldwide foundry chemical activities under the name Ask Chemicals, which will have its headquarters in Hilden, Germany. They expect to close the deal by the end of the year.
The European Commission, the EU competition watchdog, approved the joint venture and said the deal would not hamper competition in the European Economic Area (EEA).

"After examining the operation carefully, the Commission concluded that the transaction would not significantly impede effective competition in the EEA and has therefore approved the concentration," it said in a statement.

Germany's Sud-Chemie is active in speciality chemical products while U.S.-based Ashland is a manufacturer of chemical specialty and performance products as well as a distributor of chemicals and plastics.

Company

Süd-Chemie

Lenbachplatz 6
80333 München
Germany

Company contact







CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.